Palisade Bio Valuation
| PALI Stock | USD 1.48 0.18 10.84% |
Based on Macroaxis valuation methodology, the company appears to be undervalued. Palisade Bio holds a recent Real Value of $8.68 per share. The prevailing price of the company is $1.48. Our model determines the value of Palisade Bio from analyzing the company fundamentals such as Shares Owned By Institutions of 3.57 %, shares outstanding of 2.77 M, and Return On Equity of -1.1 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Palisade Bio's valuation include:
Price Book 0.6645 | Enterprise Value | Enterprise Value Ebitda 0.5714 | Price Sales 14.0311 | Enterprise Value Revenue 234.8894 |
Undervalued
Today
Please note that Palisade Bio's price fluctuation is risky at this time. Calculation of the real value of Palisade Bio is based on 3 months time horizon. Increasing Palisade Bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Palisade Bio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Palisade Stock. However, Palisade Bio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.48 | Real 8.68 | Target 30.33 | Hype 0.97 |
The intrinsic value of Palisade Bio's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Palisade Bio's stock price.
Estimating the potential upside or downside of Palisade Bio helps investors to forecast how Palisade stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Palisade Bio more accurately as focusing exclusively on Palisade Bio's fundamentals will not take into account other important factors: When choosing an evaluation method for Palisade Bio, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.
Palisade Bio Cash |
|
Palisade Valuation Trend
Palisade Bio's real value analysis enables investors to forecast the earnings more efficiently. Using both Palisade Bio's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing decisions.
Palisade Bio Total Value Analysis
Palisade Bio is at this time expected to have valuation of (3.29 M) with market capitalization of 4.92 M, debt of 369 K, and cash on hands of 5 M. The negative valuation of Palisade Bio may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Palisade Bio fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(3.29 M) | 4.92 M | 369 K | 5 M |
Palisade Bio Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Palisade Bio has an asset utilization ratio of 1.78 percent. This signifies that the Company is making $0.0178 for each dollar of assets. An increasing asset utilization means that Palisade Bio is more efficient with each dollar of assets it utilizes for everyday operations.Palisade Bio Ownership Allocation
Roughly 94.55 pct. of Palisade Bio outstanding shares are held by general public with 1.88 % owned by insiders and only 3.57 (%) by third-party entities.Palisade Bio Profitability Analysis
The company reported the previous year's revenue of 250 K. Net Loss for the year was (12.3 M) with profit before overhead, payroll, taxes, and interest of 0.About Palisade Bio Valuation
An absolute valuation paradigm, as applied to Palisade Stock, attempts to find the value of Palisade Bio based on its fundamental and basic technical indicators. By analyzing Palisade Bio's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Palisade Bio's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Palisade Bio. We calculate exposure to Palisade Bio's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Palisade Bio's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 225 K | 128.8 K | |
| Pretax Profit Margin | (56.58) | (59.41) | |
| Operating Profit Margin | (60.12) | (63.13) | |
| Net Loss | (56.58) | (59.41) | |
| Gross Profit Margin | (11.27) | (10.71) |
Palisade Bio Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 456 K |
Palisade Bio Current Valuation Indicators
Valuation refers to the process of determining the present value of Palisade Bio and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Palisade we look at many different elements of the entity such as Palisade's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Palisade Bio, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Palisade Bio's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Palisade Bio's worth.Complementary Tools for Palisade Stock analysis
When running Palisade Bio's price analysis, check to measure Palisade Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Palisade Bio is operating at the current time. Most of Palisade Bio's value examination focuses on studying past and present price action to predict the probability of Palisade Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Palisade Bio's price. Additionally, you may evaluate how the addition of Palisade Bio to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |